login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Terumo introduces Azur Detachable 35 Peripheral Framing Coil


Monday, 02 Apr 2012 12:34
Azur coils
Azur coils

Terumo Interventional Systems, one of the leading manufacturers of guidewires, catheters, sheaths, and embolization products, has announced the US availability of the Azur D35 Framing Coil for peripheral embolization procedures.


Azur is indicated for peripheral embolization procedures where a scaffolding structure is needed, such as: hypogastric artery embolization; peripheral arteriovenous malformations and fistulas; endoleaks; visceral aneurysms; and venous applications. The detachable embolic platform forms a spherical 3-dimensional shape when deployed and is designed to control the first coil deployment, when a standard coil would not suffice due to high flow and high pressures.


“The new Azur D35 Framing Coils’ innovative technology offers interventional radiologists and vascular surgeons options in challenging, high-flow procedures,” said Chris Pearson, vice president, Marketing, Terumo Interventional Systems. “These detachable framing coils afford greater filling capacity, packing density, and mechanical occlusion, particularly in the treatment of high-flow and challenging blood vessels, vascular malformations, and aneurysms.”


“The detachable technology allows the physician to optimise the framing coil placement, creating support for subsequent coils,” said Pearson. “Azur D35 Hydrogel coils expand gradually upon exposure to blood, which provides improved volumetric filling allowing highly effective, targeted embolization.”




Add New Comment

Most popular


First patient enrolled in US study of Novate’s Sentry IVC filter
Monday, 22 Sep 2014
Novate Medical has announced that Souheil Saddekni, professor of Vascular and Interventional Radiology at the University of Alabama, Birmingham, USA, has enrolled the first patient in the SENTRY IDE ... First patient enrolled in US study of Novate’s Sentry IVC filter

First drug-eluting balloon approved in USA
Friday, 10 Oct 2014
The FDA has approved the Lutonix drug-eluting balloon for the management of peripheral artery disease. This is the first time that the agency has approved such a device for this indication in the USA. First drug-eluting balloon approved in USA

CIRSE 2014 audience needs more evidence before they support drug-elution in the superficial femoral artery
Friday, 26 Sep 2014
The audience in the CIRSE 2014 “Controversies in superficial femoral artery treatment” session failed to endorse two motions pertaining to drug-elution in this anatomical segment in the annual ... CIRSE 2014 audience needs more evidence before they support drug-elution in the superficial femoral artery

Features


What the trials have taught us about aggressive therapy of deep venous thrombosis
Thursday, 25 Sep 2014
Although current evidence in favour of catheter-directed thrombolysis for deep venous thrombosis may not be robust enough to allow for a shift in clinical practice, that may soon change with strict ... What the trials have taught us about aggressive therapy of deep venous thrombosis

The promise of chemical renal denervation
Friday, 05 Sep 2014
Tim A Fischell writes that chemical renal denervation using ethanol may have numerous advantages over energy-based “burning” technologies. The promise of chemical renal denervation

Profiles


José Ignacio Bilbao Jaureguízar
Wednesday, 08 Oct 2014
“No matter what their future orientation, interventional radiologists involved in interventional ... José Ignacio Bilbao Jaureguízar

Bien Soo Tan
Friday, 16 May 2014
Bien Soo Tan, senior consultant, Department of Diagnostic Radiology, Singapore General Hospital, S... Bien Soo Tan

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions